Clinic
Banner-University Medical Group
Banner-University Medical Group was paid $133.69M by Medicaid between Jan 2018 and Dec 2024, across 458 billing codes. Its largest line is 99285, emergency room visit (most serious) — 13% of everything it billed.
33Billing provider infoBANNER-UNIVERSITY MEDICAL GROUP
PHOENIX, AZ 85012
PHOENIX, AZ 85012
33aNPI1508809427assigned 06/14/2006
33bProvider typePrimary Care Clinic/Center
28Total paid$133.69M
24GClaims2,458,194
24DCodes billed458
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Arizona
Rank by total paid#1 of 104
Median peer was paid$181K
This provider vs. median738×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 295,363 | $17.93M | |
| 2019 | 380,218 | $21.95M | |
| 2020 | 328,666 | $15.96M | |
| 2021 | 400,931 | $21.72M | |
| 2022 | 362,404 | $19.13M | |
| 2023 | 396,494 | $21.19M | |
| 2024incomplete | 294,118 | $15.82M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 143,428 | 137,282 | $17.78M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 213,571 | 196,072 | $13.72M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.2% | 114,554 | 110,955 | $10.91M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.0% | 164,692 | 151,417 | $8.06M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.3% | 107,389 | 41,509 | $7.09M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.5% | 131,577 | 54,379 | $6.04M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 3.9% | 36,381 | 13,936 | $5.20M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.5% | 83,155 | 81,159 | $4.70M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.9% | 44,298 | 39,524 | $3.94M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 41,402 | 39,478 | $3.09M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 37,772 | 35,331 | $2.25M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 22,060 | 21,112 | $2.22M |
446 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.2% | 49,115 | $1.64M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.2% | 5,223 | $1.60M |
| 99469 | Subsequent inpatient neonatal critical care, per day, 28 days or younger | 1.2% | 4,101 | $1.59M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.1% | 24,454 | $1.41M |
| 99223 | Prolong inpt eval add15 m | 1.0% | 11,579 | $1.40M |
| 71045 | Radiologic examination, chest; single view | <1% | 172,532 | $1.30M |
| 99480 | Subsequent intensive care, per day, low birth weight infant | <1% | 10,698 | $1.25M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13,970 | $1.25M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 11,682 | $1.21M |
| 74183 | <1% | 12,571 | $1.20M | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 11,811 | $1.20M |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17,747 | $1.19M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 11,370 | $1.09M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 52,781 | $1.01M |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 20,383 | $980K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 17,711 | $864K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 24,889 | $850K |
| 99479 | Subsequent intensive care, per day, very low birth weight infant | <1% | 6,781 | $825K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 7,533 | $823K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 8,212 | $804K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 5,347 | $721K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 111,100 | $714K |
| 88307 | <1% | 7,428 | $670K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 8,529 | $646K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 4,333 | $615K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 6,427 | $549K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 4,142 | $542K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12,600 | $530K |
| 72197 | <1% | 5,663 | $514K | |
| 99472 | Subsequent inpatient pediatric critical care, per day, 2-5 years | <1% | 1,223 | $485K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 7,409 | $471K |
| 93975 | <1% | 8,459 | $459K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 2,730 | $455K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 1,736 | $438K |
| 99205 | Prolong outpt/office vis | <1% | 3,880 | $436K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 6,620 | $436K |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement | <1% | 4,145 | $426K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 39,471 | $407K |
| 59025 | Fetal non-stress test | <1% | 8,863 | $377K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 8,731 | $377K |
| 31231 | <1% | 2,330 | $370K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 5,568 | $370K |
| 71250 | <1% | 8,992 | $349K | |
| 76830 | Ultrasound, transvaginal | <1% | 3,707 | $337K |
| 93976 | <1% | 9,361 | $323K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,965 | $321K |
| 72131 | <1% | 7,814 | $314K | |
| 99443 | <1% | 5,572 | $306K | |
| 72128 | <1% | 6,500 | $260K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,297 | $258K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 3,862 | $250K |
| 31237 | <1% | 818 | $243K | |
| 74018 | <1% | 32,221 | $241K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 3,057 | $236K |
| 00731 | <1% | 2,424 | $236K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 9,405 | $232K |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | <1% | 488 | $214K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 8,997 | $214K |
| 90837 | Psychotherapy session, about an hour | <1% | 2,014 | $207K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,068 | $197K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,417 | $178K |
| 73630 | <1% | 19,226 | $175K | |
| 90961 | <1% | 1,230 | $172K | |
| 76770 | <1% | 5,852 | $167K | |
| 70486 | <1% | 3,958 | $161K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 490 | $150K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,483 | $150K |
| 97802 | <1% | 1,327 | $147K | |
| 93320 | <1% | 4,343 | $146K | |
| 86077 | <1% | 5,104 | $140K | |
| 0002A | <1% | 4,017 | $136K | |
| 73610 | <1% | 13,850 | $133K | |
| 20610 | <1% | 3,171 | $130K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 1,103 | $128K |
| 0001A | <1% | 4,036 | $126K | |
| 94010 | <1% | 4,080 | $125K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 3,208 | $123K |
| 49083 | <1% | 1,646 | $118K | |
| 99460 | <1% | 1,631 | $117K | |
| 73562 | <1% | 13,963 | $116K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 649 | $113K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,372 | $112K |
| 92083 | <1% | 2,871 | $109K | |
| 93325 | <1% | 9,405 | $109K | |
| 31575 | <1% | 1,144 | $109K | |
| 92015 | Determination of refractive state | <1% | 5,694 | $107K |
| 96112 | <1% | 860 | $105K | |
| 70498 | <1% | 1,512 | $105K | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 85 | $104K |
| 73030 | <1% | 12,183 | $103K | |
| 93971 | <1% | 5,860 | $102K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 6,647 | $99K |
| 90686 | <1% | 22,641 | $97K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 357 | $97K |
| 76642 | <1% | 1,757 | $97K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 754 | $94K |
| 93970 | <1% | 3,646 | $94K | |
| 73130 | <1% | 10,822 | $90K | |
| 88342 | <1% | 2,983 | $87K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,307 | $86K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 4,858 | $84K |
| 95886 | <1% | 695 | $84K | |
| 64615 | <1% | 857 | $81K | |
| 90461 | <1% | 3,803 | $80K | |
| 77066 | Tomosynthesis, mammo | <1% | 796 | $80K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 606 | $78K |
| 97803 | <1% | 1,306 | $74K | |
| 73110 | <1% | 6,820 | $72K | |
| 73590 | <1% | 9,930 | $72K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 343 | $67K |
| 92551 | <1% | 12,653 | $65K | |
| 99243 | <1% | 515 | $65K | |
| 11721 | <1% | 3,713 | $65K | |
| 95720 | <1% | 386 | $64K | |
| 92134 | <1% | 2,339 | $64K | |
| 99442 | <1% | 2,007 | $64K | |
| 88112 | <1% | 2,862 | $63K | |
| 95811 | <1% | 580 | $62K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,193 | $60K |
| 77014 | <1% | 1,810 | $58K | |
| 92133 | <1% | 2,684 | $58K | |
| 00811 | <1% | 633 | $56K | |
| 99221 | <1% | 853 | $55K | |
| 93272 | <1% | 2,702 | $54K | |
| 99217 | <1% | 1,397 | $53K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,953 | $52K |
| 51798 | <1% | 6,648 | $51K | |
| 52000 | <1% | 560 | $51K | |
| 80504 | <1% | 1,151 | $47K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 869 | $46K |
| 88304 | <1% | 4,304 | $46K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 1,543 | $45K |
| 99242 | <1% | 488 | $45K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,772 | $44K |
| 99417 | Prolong home eval add 15m | <1% | 1,532 | $43K |
| 72170 | <1% | 6,151 | $43K | |
| 99220 | <1% | 429 | $43K | |
| 77080 | <1% | 2,992 | $39K | |
| 73502 | <1% | 4,080 | $38K | |
| 92250 | <1% | 1,234 | $37K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 556 | $36K |
| 93308 | <1% | 1,855 | $35K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 1,198 | $34K |
| 99254 | <1% | 234 | $34K | |
| 0012A | <1% | 1,222 | $34K | |
| 70496 | <1% | 519 | $34K | |
| 99385 | <1% | 318 | $34K | |
| 77427 | <1% | 257 | $34K | |
| 99441 | <1% | 1,353 | $32K | |
| 72100 | <1% | 2,789 | $31K | |
| 76857 | <1% | 1,210 | $31K | |
| 43235 | <1% | 339 | $31K | |
| 92504 | <1% | 1,294 | $30K | |
| 73090 | <1% | 3,805 | $30K | |
| 00732 | <1% | 228 | $29K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,373 | $29K |
| 00813 | <1% | 276 | $29K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,390 | $29K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 431 | $29K |
| 93000 | <1% | 1,669 | $28K | |
| 95117 | <1% | 2,443 | $28K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,339 | $28K |
| 73552 | <1% | 3,723 | $27K | |
| 96111 | <1% | 236 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 778 | $27K |
| 88341 | <1% | 449 | $27K | |
| 99219 | <1% | 357 | $26K | |
| 95806 | <1% | 669 | $26K | |
| 99177 | <1% | 3,268 | $26K | |
| 70491 | <1% | 400 | $25K | |
| 90716 | <1% | 308 | $25K | |
| 0011A | <1% | 1,279 | $25K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 140 | $23K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 584 | $23K |
| 90473 | <1% | 1,260 | $23K | |
| 73564 | <1% | 2,118 | $23K | |
| 99468 | <1% | 24 | $23K | |
| 88173 | <1% | 304 | $22K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 505 | $22K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 112 | $21K |
| 93798 | <1% | 2,116 | $20K | |
| 88350 | <1% | 150 | $20K | |
| 90651 | <1% | 890 | $20K | |
| 0071A | <1% | 304 | $19K | |
| 90746 | <1% | 341 | $19K | |
| 0072A | <1% | 286 | $18K | |
| 95012 | <1% | 844 | $18K | |
| 72141 | <1% | 280 | $18K | |
| 21085 | <1% | 35 | $18K | |
| 90474 | <1% | 930 | $17K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 127 | $17K |
| 99152 | <1% | 1,759 | $16K | |
| 94060 | <1% | 1,324 | $16K | |
| 00812 | <1% | 159 | $16K | |
| 73560 | <1% | 2,115 | $15K | |
| 99255 | <1% | 79 | $15K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 365 | $15K |
| 95819 | <1% | 312 | $14K | |
| 99173 | <1% | 8,657 | $14K | |
| 76825 | <1% | 72 | $14K | |
| 95816 | <1% | 304 | $14K | |
| 99292 | <1% | 161 | $14K | |
| 92002 | <1% | 156 | $13K | |
| 43264 | <1% | 62 | $13K | |
| 90715 | <1% | 518 | $13K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 34 | $12K |
| 77065 | Tomosynthesis, mammo | <1% | 157 | $12K |
| 77049 | <1% | 57 | $12K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 911 | $12K |
| 95251 | <1% | 344 | $12K | |
| 70546 | <1% | 230 | $12K | |
| 36558 | <1% | 49 | $11K | |
| 90632 | <1% | 238 | $11K | |
| 88108 | <1% | 670 | $11K | |
| 73700 | <1% | 284 | $10K | |
| 99383 | <1% | 104 | $10K | |
| 70548 | <1% | 172 | $10K | |
| 76801 | <1% | 162 | $10K | |
| 93321 | <1% | 1,189 | $10K | |
| 90480 | <1% | 359 | $9K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 264 | $9K |
| 76536 | <1% | 310 | $9K | |
| 73080 | <1% | 1,204 | $9K | |
| 92020 | <1% | 549 | $9K | |
| 94729 | <1% | 1,120 | $9K | |
| 76506 | <1% | 270 | $9K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 70 | $9K |
| 99403 | <1% | 126 | $9K | |
| 93922 | <1% | 1,116 | $9K | |
| 95911 | <1% | 41 | $8K | |
| 90707 | <1% | 159 | $8K | |
| 11102 | <1% | 126 | $8K | |
| 00520 | <1% | 74 | $8K | |
| 95951 | <1% | 42 | $8K | |
| 95885 | <1% | 98 | $8K | |
| 94726 | <1% | 813 | $8K | |
| 99462 | <1% | 258 | $8K | |
| 97156 | <1% | 222 | $8K | |
| 81003 | <1% | 5,627 | $8K | |
| 73060 | <1% | 1,119 | $8K | |
| 88313 | <1% | 359 | $8K | |
| 76377 | <1% | 206 | $7K | |
| 64616 | <1% | 97 | $7K | |
| 51600 | <1% | 73 | $7K | |
| 88311 | <1% | 587 | $7K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 104 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,220 | $7K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,698 | $7K |
| 81025 | <1% | 991 | $7K | |
| 77001 | <1% | 523 | $7K | |
| 88189 | <1% | 100 | $7K | |
| 82962 | <1% | 2,640 | $7K | |
| 93280 | <1% | 182 | $6K | |
| 10005 | <1% | 75 | $6K | |
| 46600 | <1% | 65 | $6K | |
| 93018 | <1% | 591 | $6K | |
| 87428 | <1% | 102 | $6K | |
| 73701 | <1% | 116 | $6K | |
| 73720 | <1% | 45 | $6K | |
| 90962 | <1% | 53 | $5K | |
| 72040 | <1% | 517 | $5K | |
| 74328 | <1% | 238 | $5K | |
| 74019 | <1% | 434 | $5K | |
| 93228 | <1% | 258 | $5K | |
| 20611 | <1% | 74 | $5K | |
| 75574 | <1% | 62 | $5K | |
| 76813 | <1% | 38 | $5K | |
| 78832 | <1% | 62 | $5K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 69 | $5K |
| 80503 | <1% | 189 | $4K | |
| 72158 | <1% | 48 | $4K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 783 | $4K |
| 70543 | <1% | 40 | $4K | |
| 11055 | <1% | 131 | $4K | |
| 76827 | <1% | 72 | $4K | |
| 93288 | <1% | 281 | $4K | |
| 99477 | <1% | 12 | $4K | |
| 72110 | <1% | 169 | $4K | |
| 95782 | <1% | 15 | $4K | |
| 96130 | <1% | 40 | $4K | |
| 90734 | <1% | 171 | $4K | |
| 92060 | <1% | 50 | $4K | |
| 92136 | <1% | 110 | $4K | |
| 51705 | <1% | 68 | $4K | |
| 11056 | <1% | 82 | $4K | |
| 51728 | <1% | 72 | $3K | |
| 73221 | <1% | 39 | $3K | |
| 92025 | <1% | 123 | $3K | |
| 69210 | <1% | 109 | $3K | |
| 17311 | <1% | 13 | $3K | |
| 84703 | <1% | 490 | $3K | |
| 76882 | <1% | 149 | $3K | |
| 73100 | <1% | 152 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 82 | $3K |
| 93880 | <1% | 110 | $3K | |
| 73140 | <1% | 311 | $3K | |
| 99382 | <1% | 36 | $3K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 23 | $3K |
| 88302 | <1% | 294 | $3K | |
| 43244 | <1% | 14 | $3K | |
| 97804 | <1% | 58 | $2K | |
| 73620 | <1% | 312 | $2K | |
| 93458 | <1% | 15 | $2K | |
| 99226 | <1% | 70 | $2K | |
| 93298 | <1% | 139 | $2K | |
| 15002 | <1% | 13 | $2K | |
| 90945 | <1% | 31 | $2K | |
| 20553 | <1% | 58 | $2K | |
| 51741 | <1% | 346 | $2K | |
| 96131 | <1% | 15 | $2K | |
| 88346 | <1% | 89 | $2K | |
| 93289 | <1% | 86 | $2K | |
| 99418 | Prolong nursin fac eval 15m | <1% | 34 | $2K |
| 76870 | <1% | 71 | $2K | |
| 36589 | <1% | 27 | $2K | |
| 99201 | <1% | 70 | $2K | |
| 51797 | <1% | 64 | $2K | |
| 74174 | <1% | 28 | $2K | |
| 76937 | <1% | 183 | $2K | |
| 92201 | <1% | 66 | $2K | |
| 93926 | <1% | 122 | $2K | |
| 96450 | <1% | 15 | $2K | |
| 88312 | <1% | 79 | $2K | |
| 85060 | <1% | 127 | $2K | |
| 99349 | <1% | 49 | $2K | |
| 99384 | <1% | 13 | $2K | |
| 93923 | <1% | 110 | $1K | |
| 90732 | <1% | 16 | $1K | |
| 96161 | <1% | 518 | $1K | |
| 93454 | <1% | 12 | $1K | |
| 96136 | <1% | 40 | $1K | |
| 31579 | <1% | 13 | $1K | |
| 93304 | <1% | 14 | $1K | |
| 99381 | <1% | 12 | $1K | |
| 73600 | <1% | 130 | $1K | |
| 95812 | <1% | 18 | $1K | |
| 0111A | <1% | 13 | $1K | |
| 99225 | <1% | 41 | $1K | |
| 99305 | <1% | 14 | $1K | |
| 90670 | <1% | 5,018 | $1K | |
| 88348 | <1% | 14 | $1K | |
| 20550 | <1% | 28 | $1K | |
| 27096 | <1% | 14 | $1K | |
| 0112A | <1% | 12 | $999.33 | |
| 11730 | <1% | 14 | $928.70 | |
| 93356 | <1% | 91 | $927.04 | |
| 99306 | Prolong nursin fac eval 15m | <1% | 12 | $903.19 |
| 90714 | <1% | 52 | $876.40 | |
| 90674 | <1% | 39 | $875.62 | |
| Q0247 | Injection, sotrovimab, 500 mg | <1% | 65 | $869.97 |
| 78816 | <1% | 15 | $850.44 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 28 | $837.07 |
| 99218 | <1% | 12 | $820.88 | |
| 77334 | <1% | 40 | $818.93 | |
| 77012 | <1% | 12 | $805.28 | |
| 96380 | <1% | 41 | $804.09 | |
| 36556 | <1% | 18 | $793.95 | |
| 99464 | <1% | 12 | $750.48 | |
| 73201 | <1% | 12 | $697.91 | |
| 93296 | <1% | 48 | $680.39 | |
| 93016 | <1% | 38 | $680.31 | |
| 73070 | <1% | 93 | $675.96 | |
| 93248 | <1% | 34 | $664.78 | |
| 99402 | <1% | 13 | $635.13 | |
| 11719 | <1% | 90 | $621.35 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 56 | $596.96 |
| 73200 | <1% | 13 | $556.75 | |
| 17000 | <1% | 14 | $464.43 | |
| 93990 | <1% | 26 | $456.16 | |
| 76514 | <1% | 32 | $439.76 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 103 | $417.06 |
| 72050 | <1% | 25 | $390.99 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 15 | $390.27 |
| 78306 | <1% | 13 | $383.80 | |
| 93290 | <1% | 12 | $363.30 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 72 | $333.67 |
| 99497 | <1% | 16 | $327.09 | |
| 90677 | <1% | 431 | $320.31 | |
| 76604 | <1% | 13 | $315.19 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 25 | $280.90 |
| 76942 | <1% | 13 | $265.09 | |
| 51784 | <1% | 16 | $227.43 | |
| 90698 | <1% | 2,858 | $225.57 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 14 | $223.30 |
| 11720 | <1% | 18 | $173.66 | |
| 93246 | <1% | 15 | $170.64 | |
| 72070 | <1% | 13 | $167.42 | |
| 95970 | <1% | 13 | $155.09 | |
| 90697 | <1% | 511 | $152.36 | |
| 90680 | <1% | 1,813 | $145.22 | |
| 72190 | <1% | 16 | $144.78 | |
| 93270 | <1% | 20 | $144.23 | |
| 87210 | <1% | 27 | $141.47 | |
| 94618 | <1% | 13 | $135.79 | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 13 | $135.10 |
| 90713 | <1% | 29 | $113.36 | |
| 96127 | <1% | 16 | $78.11 | |
| 17003 | <1% | 12 | $74.93 | |
| 70110 | <1% | 12 | $74.34 | |
| Q0112 | All potassium hydroxide (koh) preparations | <1% | 13 | $55.01 |
| 1159F | <1% | 3,456 | $15.16 | |
| 99499 | <1% | 2,658 | $12.55 | |
| 85610 | <1% | 50 | $9.30 | |
| 36416 | <1% | 151 | $7.99 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 15 | $6.41 |
| 90744 | <1% | 483 | $2.82 | |
| 90633 | <1% | 959 | $1.92 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | <1% | 135 | $0.38 |
| Q0239 | Injection, bamlanivimab-xxxx, 700 mg | <1% | 17 | $0.12 |
| Q0240 | Injection, casirivimab and imdevimab, 600 mg | <1% | 29 | $0.08 |
| 1170F | <1% | 4,031 | $0.05 | |
| 1111F | <1% | 4,486 | $0.02 | |
| 3074F | <1% | 2,733 | $0.01 | |
| 1126F | <1% | 270 | $0.01 | |
| 1160F | <1% | 4,441 | $0.01 | |
| 4040F | <1% | 1,714 | $0.01 | |
| 90656 | 0% | 457 | $0.00 | |
| 3072F | 0% | 15 | $0.00 | |
| 91301 | 0% | 1,247 | $0.00 | |
| 3079F | 0% | 190 | $0.00 | |
| 99024 | 0% | 134 | $0.00 | |
| 4037F | 0% | 52 | $0.00 | |
| 3066F | 0% | 129 | $0.00 | |
| 85027 | 0% | 41 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 129 | $0.00 |
| 1125F | 0% | 202 | $0.00 | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 14 | $0.00 |
| 91307 | 0% | 192 | $0.00 | |
| 83735 | 0% | 42 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 586 | $0.00 |
| 90688 | 0% | 201 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 176 | $0.00 |
| 90696 | 0% | 12 | $0.00 | |
| 4255F | 0% | 26 | $0.00 | |
| 3078F | 0% | 2,244 | $0.00 | |
| 91300 | 0% | 5,139 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 360 | $0.00 |
| 90685 | 0% | 419 | $0.00 | |
| 0502F | 0% | 156 | $0.00 | |
| 3077F | 0% | 53 | $0.00 | |
| 90681 | 0% | 45 | $0.00 | |
| 91321 | 0% | 46 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 28 | $0.00 |
| 2022F | 0% | 15 | $0.00 | |
| 84100 | 0% | 41 | $0.00 | |
| G9771 | At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHWARTZ, BENJAMIN (PRESIDENT)
Parent organizationBANNER HEALTH